The amino acid sequence of elastase inhibitor, AFLEI, isolated from Aspergillus flavus was determined by the Edman sequencing procedure of peptides derived from digests utilizing clostripain. A molecular weight of 7,525.8 was observed by TOF-MS. AFLEI contained 68 amino acid residues and has a calculated molecular weight of 7,526.2. The search for amino acid homology with other proteins demonstrated that amino acid residues 1 to 51 of AFLEI are 100% identical to residues 20 to 70 of the hypothetical protein Afu3g14940.
INTRODUCTION
Aspergillus species are the common fungi of all environments 1 . Conidia of these fungi are airborne and found in the atmosphere throughout the world. Aspergillosis is caused by inhalation of high spore concentrations of the Aspergillus species and is one of the most important systemic mycoses. Invasive aspergillosis caused by pathogenic Aspergillus species is a serious hazard for an immunocompromised patient and the number of patients whose immune systems are compromised by either congenital or immune deficiency states has increased recently.
Elastase-producing strains promote a higher death rate in immunodeficient mice than nonelastase producing strains. Elastase-producing strains destroy lung tissue 2, 3 and an elastase produced by Aspergillus is confirmed as a definitive virulence factor of Aspergillosis 4 . Ulinastatin, which contains an enzyme inhibitor, was administered by way of intravenous drip infusion concomitantly with antifungal agents to patients of pulmonary aspergillosis 5 9 . It is very likely that the elastase inhibitor is an effective therapy of aspergillosis. It has been shown that A. fumigatus and A. flavus produced elastase inhibitors 10 . Recently, we purified and characterized the elastase inhibitor AFLEI from A. flavus 11 . AFLEI has a molecular weight of 7,525.8, isoelectric point of pH 7.4 and inhibits elastase elastolytic activity from A. flavus, A. fumigatus and human leukocytes. However, the elastolytic activity of porcine pancreas elastase, trypsin, chymotrypsin, thrombin, and Ac 1 -Proteinase from snake venom was not affected. The primary structure of AFLEI was determined in order to elucidate and investigate the physiological function and biological relationship of this inhibitor. In summary, here we report the first primary structure and properties of the elastase inhibitor, AFLEI.
MATERIALS AND METHODS

Fungal strain
A. flavus AFL-1 strain was identified and isolated from the sputum of a patient with allergic bronchopulmonary aspergillosis. Elastase from A. flavus was purified by the method of Hasegawa et al. 12 .
Purification of AFLEI
AFLEI was purified from A. flavus by the method of Okumura et al. 11 . A sufficient number of microorganic spores were cultured in 100 ml of synthetic medium of 0.1% yeast carbon base Difco Lab., Detroit, MI, USA containing 1% casamino acid Difco Lab. as a nitrogen source. The cultures were incubated for 7 days at 37 C without shaking. The culture broth was filtered, and the cell-free culture supernatant was used as the source of crude inhibitor. Solid ammonium sulfate was added 60% saturation to 100 ml of the culture filtrate supernatant from A. flavus at room temperature. The resulting precipitate was collected by centrifugation at 3,000 rpm for 10 min, and dissolved in an equal volume of the original supernatant in 10 mM Tris-HCl buffer pH 7.5 . AFLEI was purified from this solution using DE52-cellulose Whatman Biosystems, Ltd., England and Sephadex G-75 Pharmacia, Uppsala, Sweden chromatographies.
Polyacrylamide gel electrophoresis and isoelectric focusing
Polyacrylamide gel electrophoresis pH 8.3 and pH 4.3 was carried out according to the method of Davis 13 . Electrophoresis was carried out on polyacrylamide gel using a constant current of 3 mA at 4 C for 3 hr.
Isoelectric focusing was performed on an ampholine polyacrylamide gel. The ampholyte concentration was 4% w/v with a pH range of 3.5-10.5 using a constant potential of 200 V at 4 C for 4 hr.
Amino acid sequence analysis
The amino acid sequence of AFLEI was analyzed by an Applied Biosystems 491 protein sequencer. The phenylthiohydantoin PTH derivatives of amino acids were identified with an Applied Biosystems Model 120A PTH analyzer in accordance with the manufacturer's instructions. Native AFLEI was digested with clostripain Roche Diagnostics K.K., Basel, Switzerland for 24 hr at 37 C in 50 mM Tris-HCl pH 7.2 containing 10 mM CaCl 2 . All digests were separated by reversed-phase HPLC.
Assay for elastase inhibitory activity
Fifty microliters of AFLEI or other inhibitors ulinastatin; Mochida Pharmaceutical Co., Ltd., Tokyo, Japan, sivelestat sodium hydrate; Ono Pharmaceutical Co., Ltd., Osaka, Japan, gabexate mesilate; Ono Pharmaceutical Co., Ltd., nafamostat mesilate; Torii Pharmaceutical Co., Ltd., Tokyo, elafin; Peptide Institute Inc, Osaka, elastatinal; Sigma Chemical Co., Ltd., St. Louis, MO, USA was mixed with 50 l of the purified elastase from A. flavus or others porcine pancreas; Sigma Chemical Co., Ltd and human leukocytes; Elastin Products Co., Inc., Missouri, USA . and incubated for 15 min at 37 C. Then 0.9 ml of 50 mM Tris-HCl buffer, pH 7.5, and 20 l of 50 mM succinyl L-alanyl-L-alanyl-L-alanyl pnitroanilide STANA Peptide Institute Inc., Osaka solution were added and incubated for 60 min at 37 C. The reaction was stopped by adding 1 ml of 10% TCA. Two-tenths ml of 0.1% sodium nitrite, 0.5% ammonium sulfamate, and 0.1% N-1-naphtyletylenediamine dihydrochloride were added to the solution and the color that developed was read at 550 nm.
RESULTS
Enzymatic Properties
The Michaelis constant Km for STANA of elastase from A. flavus at pH 7.5, was 6.7 10 2 M Fig. 1 . The inhibition constant Ki of AFLEI for elastase was determined by 
An electric change of elastase
Elastase and AFLEI were mixed together and electrophoresis was carried out on polyacrylamide gel using a constant current of 3 mA at 4 C Fig. 2 . Elastase could not be detected by polyacrylamide gel electrophoresis pH 8.3 , however, the mixed sample demonstrated a single band pH 8.3 . Additionally the mixed sample migrated to the anode pH 4.3 . This suggests that AFLEI acted on elastase resulting in a change in the electricstate. This conclusion is supported by the fact that the isoelectric point became considerably lower when elastase and AFLEI were mixed and the mixed sample was tested by isoelectric point electrophoresis.
Primary structure of AFLEI
A total of 68 amino acid residues were identified Fig. 3 and Table 1 shows the amino acid composition of AFLEI. Calculated values were derived from the result of amino acid sequence analysis. The total number of aspartic and glutamic acid residues is 9, and the combined number of lysine and arginine residues is 4. The AFLEI sequence also shows two cysteinyl residues. AFLEI was digested in clostripain and the amino acid sequence of each fragment was examined by reverse-phase high-performance Fig. 4A . The sequences of fraction 1 were determined as shown in Fig.  4B . Two peptides were detected simultaneously. From these results, it was determined that one disulfide bond of AFLEI links Cys-5 to Cys-67. AFLEI is composed of 68 amino acid residues and the molecular weight of the protein portion of AFLEI was estimated to be 7,526.2. Interestingly, the search for amino acid homology with other proteins showed that amino acid residues 1 to 51 of AFLEI are 100% identical to residues 20 to 70 of the hypothetical protein Afu3g14940 which contains 83 amino acid residues in A. fumigatus 14 , suggesting that although the function of Afu3g14940 protein is unknown, the protein may possess inhibitory activity for elastases. No tryptophan was found and a total of three aromatic amino acids two tyrosines, one phenylalanine were present. As a result, the absorption at 280 nm was minimal.
Comparison of other protease inhibitors
Inhibitory activity was compared with six other protease inhibitors Table 2 . Ulinastatin, nafamostat mesilate, sivelestat sodium hydrate, and gabexate mesilate are reagents normally used in hospitals, whereas elastatinal and elafin are laboratory reagents. AFLEI inhibited elastase from A. flavus and human leukocytes, but porcine pancreas elastase was not affected by AFLEI. By comparison with the other inhibitors, elastase from A. flavus was inhibited by elafin and human leukocyte elastase was inhibited by ulinastatin, sivelestat sodium hydrate and elafin. These results clearly demonstrate that elastase from A. flavus and human leukocytes were inhibited by very small amounts of AFLEI. The other six protease inhibitors demonstrated very weak inhibitory activity in comparison to AFLEI.
DISCUSSION
This laboratory purified an elastolytic protease from A. fumigatus, which had a molecular weight of 32,000 and pI of 9.1, respectively 15 , and demonstrated pathogenicity of elastase 16 . Additionally, we purified an elastolytic glycoprotein protease from A. flavus, which was inhibited by diisopropyl fluorophosphate. Its molecular weight and pI were 40,000 and 8.6, respectively 12 . From these results, elastases and proteases are definitely related to pathogenicity, and therefore the elastase inhibitor could be a most important treatment for aspergillosis. Most recently, we purified and characterized the elastase inhibitor AFLEI which had a molecular weight of 7,525.8 from A. flavus 11 .
Ogawa et al. 8 reported a clinical effect with a protease inhibitor. When Aspergillus invades the body, it must have nutrients to live, therefore, it is thought that Aspergillus produces a strong elastase which breaks human tissue and supplies nutrients. Development of Aspergillus weakens, however, and if this can be controlled an elevation in the therapeutic effect will result. Elastase from A. flavus was inhibited by a very small quantity of AFLEI in comparison with conventional protease inhibitors. Umezawa et al. 17 21 derived elafin from human skin. In this way various elastase inhibitors have been derived from various places and the purpose of these elastase inhibitors has been examined. Most of these inhibitors are presently in use in clinics or are being marketed as inhibitor reagents. AFLEI showed the strongest inhibition compared with the six protease inhibitors used in this experiment. Since AFLEI strongly inhibited human leucocyte elastase, it can be expected to have significant effects in the prevention of tissue disorder. When Aspergillus invades the body, elastase is produced by the leucocytes, which continues to damage tissue and to supply nutrients to support Aspergillus. If AFLEI can inhibit these elastases, development of Aspergillus and histionic breakdown are prevented. Furthermore, it is thought that AFLEI can suppress the onset of Aspergillus for a long period when it is used in combination with an immunosuppressive agent.
